Deal Analysis for February

With the slow recovery from the financial crisis and divestiture strategies undertaken by some big players, 2014 was marked by numerous exits by corporate investors in the industrials sector.

Canterbury University spin-out Tiro Lifesciences aims to transform breast cancer screening with $600,000.

The pharmaceutical company has acquired a 45% stake in Alkahest, which aims to fight diseases using plasma transplants from younger patients.

The company has announced the first 10 companies that will be resident at its South San Francisco Jlabs campus.

Stanford Health Care partners GE Ventures on Evidation Health, a big data startup with eyes on digital health.

Antibiotics developer Macrolide Pharmaceuticals has secured its first funding with a $22m round backed by Novartis, Roche and GlaxoSmithKline.